TissGeneSummary for TFF3 |
Gene summary |
Basic gene information | Gene symbol | TFF3 |
Gene name | trefoil factor 3 (intestinal) | |
Synonyms | ITF|P1B|TFI | |
Cytomap | UCSC genome browser: 21q22.3 | |
Type of gene | protein-coding | |
RefGenes | NM_003226.3, | |
Description | polypeptide P1.Btrefoil factor 3 | |
Modification date | 20141207 | |
dbXrefs | MIM : 600633 | |
HGNC : HGNC | ||
Ensembl : ENSG00000160180 | ||
HPRD : 02797 | ||
Vega : OTTHUMG00000086798 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_TFF3 | |
BioGPS: 7033 | ||
Pathway | NCI Pathway Interaction Database: TFF3 | |
KEGG: TFF3 | ||
REACTOME: TFF3 | ||
Pathway Commons: TFF3 | ||
Context | iHOP: TFF3 | |
ligand binding site mutation search in PubMed: TFF3 | ||
UCL Cancer Institute: TFF3 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | ColonThyroid gland | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | COADTHCA | |
Reference showing the relevant tissue of TFF3 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for TFF3 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRP | -3.432201826 | -0.379764326 | -3.0524375 | 1.04E-09 | 9.76E-09 |
KICH | -1.486938951 | 0.700629049 | -2.187568 | 1.81E-07 | 7.92E-07 |
LUSC | -0.482696128 | 1.46219799 | -1.944894118 | 3.14E-06 | 7.49E-06 |
KIRC | -1.412749396 | -0.34928134 | -1.063468056 | 2.59E-06 | 6.42E-06 |
HNSC | -2.288336347 | 1.438989235 | -3.727325581 | 1.66E-08 | 1.91E-07 |
THCA | 1.324878947 | 7.533387422 | -6.208508475 | 9.74E-25 | 1.44E-22 |
PRAD | 4.393691203 | 2.235043126 | 2.158648077 | 2.02E-06 | 1.34E-05 |
Top |
TissGene-miRNA for TFF3 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for TFF3 |
TissGeneSNV for TFF3 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.A90T | STAD | 1 |
p.A47V | TGCT | 1 |
p.A50T | KIRC | 1 |
p.P9R | ESCA | 1 |
p.D52G | LIHC | 1 |
p.E36K | BLCA | 1 |
p.P16S | CESC | 1 |
p.A126T | STAD | 1 |
Top |
TissGeneCNV for TFF3 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for TFF3 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BG959789 | TFF3-TFF3 | chr21:43733726 | chr21:43732270 |
Top |
TissGeneNet for TFF3 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for TFF3 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for TFF3 |
TissGeneDrug for TFF3 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for TFF3 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0024623 | Malignant neoplasm of stomach | 11 | BeFree |
umls:C0699791 | Stomach Carcinoma | 10 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 6 | BeFree |
umls:C0596263 | Carcinogenesis | 6 | BeFree |
umls:C0600139 | Prostate carcinoma | 6 | BeFree |
umls:C0678222 | Breast Carcinoma | 6 | BeFree |
umls:C1527249 | Colorectal Cancer | 6 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 5 | BeFree |
umls:C0027627 | Neoplasm Metastasis | 5 | BeFree |
umls:C0006142 | Malignant neoplasm of breast | 4 | BeFree |
umls:C0699790 | Colon Carcinoma | 4 | BeFree |
umls:C0001430 | Adenoma | 3 | BeFree |
umls:C0009319 | Colitis | 3 | BeFree |
umls:C0009324 | Ulcerative Colitis | 3 | BeFree |
umls:C0009404 | Colorectal Neoplasms | 3 | BeFree,LHGDN |
umls:C0040136 | Thyroid Neoplasm | 3 | BeFree,LHGDN |
umls:C0001973 | Alcoholic Intoxication, Chronic | 2 | BeFree |
umls:C0007102 | Malignant tumor of colon | 2 | BeFree |
umls:C0007115 | Malignant neoplasm of thyroid | 2 | BeFree |
umls:C0009375 | Colonic Neoplasms | 2 | LHGDN,RGD |
umls:C0010346 | Crohn Disease | 2 | BeFree |
umls:C0021390 | Inflammatory Bowel Diseases | 2 | BeFree |
umls:C0032002 | Pituitary Diseases | 2 | BeFree |
umls:C0032927 | Precancerous Conditions | 2 | BeFree,RGD |
umls:C0038356 | Stomach Neoplasms | 2 | BeFree |
umls:C0040137 | Thyroid Nodule | 2 | BeFree |
umls:C0178874 | Tumor Progression | 2 | BeFree |
umls:C0205647 | Follicular adenoma | 2 | BeFree |
umls:C0238463 | Papillary thyroid carcinoma | 2 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 2 | BeFree,GAD |
umls:C0549473 | Thyroid carcinoma | 2 | BeFree |
umls:C0686619 | Secondary malignant neoplasm of lymph node | 2 | BeFree |
umls:C1458155 | Mammary Neoplasms | 2 | BeFree |
umls:C1709246 | Non-Neoplastic Disorder | 2 | BeFree |
umls:C2239176 | Liver carcinoma | 2 | BeFree,LHGDN |
umls:C0005684 | Malignant neoplasm of urinary bladder | 1 | GAD |
umls:C0007113 | Rectal Carcinoma | 1 | BeFree |
umls:C0007130 | Mucinous Adenocarcinoma | 1 | LHGDN |
umls:C0007137 | Squamous cell carcinoma | 1 | BeFree |
umls:C0007570 | Celiac Disease | 1 | BeFree |
umls:C0008312 | Primary biliary cirrhosis | 1 | BeFree |
umls:C0014170 | Endometrial Neoplasms | 1 | LHGDN |
umls:C0014173 | Endometrial Hyperplasia | 1 | BeFree,LHGDN |
umls:C0015934 | Fetal Growth Retardation | 1 | RGD |
umls:C0016977 | Gall Bladder Diseases | 1 | BeFree |
umls:C0018133 | Graft-vs-Host Disease | 1 | BeFree,LHGDN |
umls:C0019188 | Hepatitis, Animal | 1 | CTD_human |
umls:C0019196 | Hepatitis C | 1 | BeFree |
umls:C0021053 | Immune System Diseases | 1 | BeFree |
umls:C0022658 | Kidney Diseases | 1 | CTD_human |
umls:C0023440 | Acute Erythroblastic Leukemia | 1 | BeFree |
umls:C0023892 | Biliary cirrhosis | 1 | LHGDN |
umls:C0024117 | Chronic Obstructive Airway Disease | 1 | GAD |
umls:C0027430 | Nasal Polyps | 1 | BeFree |
umls:C0032580 | Adenomatous Polyposis Coli | 1 | BeFree |
umls:C0032584 | polyps | 1 | LHGDN |
umls:C0035335 | Retinoblastoma | 1 | BeFree |
umls:C0038362 | Stomatitis | 1 | BeFree |
umls:C0151468 | Thyroid Gland Follicular Adenoma | 1 | BeFree |
umls:C0152018 | Esophageal carcinoma | 1 | BeFree |
umls:C0153690 | Secondary malignant neoplasm of bone | 1 | BeFree |
umls:C0235974 | Pancreatic carcinoma | 1 | BeFree |
umls:C0267446 | Acute gastroenteritis | 1 | BeFree |
umls:C0267809 | Cirrhosis, Cryptogenic | 1 | BeFree |
umls:C0280100 | Solid tumour | 1 | BeFree |
umls:C0302358 | Disease caused by Shigella dysenteriae | 1 | BeFree |
umls:C0333355 | Inflammatory disease of mucous membrane | 1 | CTD_human |
umls:C0333983 | Hyperplastic Polyp | 1 | BeFree |
umls:C0334342 | Skin appendage adenoma | 1 | BeFree |
umls:C0342199 | Iodine deficiency syndrome | 1 | BeFree |
umls:C0346647 | Malignant neoplasm of pancreas | 1 | BeFree |
umls:C0403447 | Chronic Kidney Insufficiency | 1 | BeFree |
umls:C0476089 | Endometrial Carcinoma | 1 | BeFree |
umls:C0524662 | Opiate Addiction | 1 | BeFree |
umls:C0566602 | Primary sclerosing cholangitis | 1 | BeFree |
umls:C0867389 | Chronic graft-versus-host disease | 1 | BeFree |
umls:C0920646 | Renal ischaemia | 1 | BeFree |
umls:C1257930 | Mammary Carcinoma, Human | 1 | BeFree |
umls:C1561643 | Chronic Kidney Diseases | 1 | BeFree |
umls:C1568868 | Oral Mucositis | 1 | BeFree |
umls:C1704272 | Benign Prostatic Hyperplasia | 1 | BeFree |
umls:C2609414 | Acute kidney injury | 1 | CTD_human |
umls:C3275124 | Biliary System Disorder | 1 | BeFree |
umls:C3809250 | ESTROGEN RESISTANCE | 1 | BeFree |